Immune-Related Adverse Drug Reactions and Immunologically Mediated Drug Hypersensitivity

Rheumatoid Arthritis

Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice

Clin Exp Rheumatol.

Leon L, Gomez A, Vadillo C, Pato E, Rodriguez-Rodriguez L, Jover JA, Abasolo L

Hypersensitivity

Severe Hypersensitivity Reactions to Biological Drugs in Children with Rheumatic Diseases

Pediatr Allergy Immunol.

Soyer O, Demir S, Bilginer Y, Batu ED, Sonmez EH, Arıcı SZ, Şahiner ÜM, Sekerel BE, Ozen S

doi: 10.1111/pai.13114.

Allergic Diseases

A Multicenter retrospective study on hypersensitivity reactions to Non-Steroidal Anti-inflammatory Drugs (NSAIDs) in children: a report from the European Network on Drug Allergy (ENDA) group

J Allergy Clin Immunol Pract.

Francesca M, Marina AM, Natalia BL, Eva G, Francesco G, Lucrezia S, Marcel M B, Vladimir T, Rocco L V, Jean-Christoph C

doi: 10.1016/j.jaip.2019.10.049.

COMMENTED

Immunotherapy

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

★ 3 Recommended and commented by Prof. Dr Dr Sacha Rothschild, Faculty Member

Eur J Cancer

Ghisoni E, Wicky A, Bouchaab H, Imbimbo M, Delyon J, Gautron Moura B, Gérard CL, Latifyan S, Özdemir BC, Caikovski M, Pradervand S, Tavazzi E, Gatta R, Marandino L, Valabrega G, Aglietta M, Obeid M, Homicsko K, Mederos Alfonso NN, Zimmermann S, Coukos G, Peters S, Cuendet MA, Di Maio M, Michielin O

doi: 10.1016/j.ejca.2021.03.010

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea

J Allergy Clin Immunol Pract.

Kang DY, Yun J, Lee SY, Koh YI, Sim DW, Kim S, Nam YH, Park JW, Kim SH, Ye YM, Park HK, Kim MH, Jee YK, Jung JW, Yang MS, Kim SH, Lee JK, Kim CW, Hur GY, Kim MY, Park SJ, Kwon YE, Choi JH, Kim JH, Kim SH, La HO, Kang MG, Park CS, Lee SM, Jeong YY, Kim HK, Jin HJ, Jeong JW, Lee J, Lee YW, Lee SE, Kim MS, Kang HR, Korean Severe Cutaneous Adverse Reactions Consortium.

doi: 10.1016/j.jaip.2020.09.011.

Hypersensitivity

The role of drug, dose and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndrome (MDH)

Allergy.

Jörg L, Yerly D, Helbling A, Pichler W

doi: 10.1111/all.14146.

Further Publications Rheumatology

Predictors of rheumatic immune-related adverse events and de novo inflammatory arthritis after immune checkpoint inhibitor treatment for cancer

Arthritis Rheumatol

Cunningham-Bussel A, Wang J, Prisco LC, Martin LW, Vanni KMM, Zaccardelli A, Nasrallah M, Gedmintas L, MacFarlane LA, Shadick NA, Awad MM, Rahma O, LeBoeuf NR, Gravallese EM, Sparks JA

doi: 10.1002/art.41949

Melanoma and Skin Cancer

C-reactive protein as a biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant setting

Melanoma Res

Lauwyck J, Beckwée A, Santens A, Schwarze JK, Awada G, Vandersleyen V, Aspeslagh S, Neyns B

doi: 10.1097/CMR.0000000000000748

Immunodeficiency

Adverse reactions in a large cohort of patients with inborn errors of immunity receiving intravenous immunoglobulin

Clin Immunol

Esmaeilzadeh H, Askarisarvestani A, Hosseini N, Samimi S, Shafiei A, Mahdaviani SA, Eslami N, Chavoshzadeh Z, Fallahi M, Khakbazanfard N, Shabestari MS, Aleyasin S, Nabavizadeh SH, Cheraghi T, Kalantari A, Ahmadiafshar A, Safari M, Eslamian MH, Molatefi R, Shirkani A, Heidarzadeh M, Tavakol M, Bemanian MH, Arshi S, Nabavi M, Shokri S, Shahhosseini B, Mortazavi N, Nakhaei P, Nazari F, Fallahpour M, Ahanchian H, Moazzen N, Khoshkhui M, Motlagh AV, Aghamohammadi A, Abolhassani H, Yazdani R, Rezaei N

doi: 10.1016/j.clim.2021.108826

Related content